Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Benzodiazepines compromise the outcome of cancer immunotherapy

Open access

Abstract

) acts on the gamma-amino butyric acid (GABA) receptor type A via a specific binding site that is shared by diazepam and other benzodiazepines. Both ACBP/DBI and benzodiazepines act as positive allosteric modulators, hence increasing GABA effects on this receptor. Recently, we found that ACBP/DBI acts as an endogenous immunosuppressor, meaning that its antibody-mediated neutralization has immunostimulatory effects and enhances the efficacy of immunotherapy and chemoimmunotherapy in mouse models. Driven by these considerations, we investigated whether diazepam administration in mice would reverse the beneficial effects of ACBP/DBI neutralization on cancer chemoimmunotherapy. Indeed, diazepam abolished the therapeutic of anti-ACBP/DBI antibodies, supporting the idea that diazepam exerts immunosuppressive properties. Of note, treatment with benzodiazepines was associated with poor clinical responses to chemoimmunotherapy in patients with non-small cell lung cancer (NSCLC) as compared to individuals not receiving any psychotropic drugs. Medication with other psychotropic drugs than benzodiazepines did not compromise the outcome of chemoimmunotherapy, indicating that this immunosuppressive effect was benzodiazepine specific. We conclude that benzodiazepines may confer systemic immunosuppression. This hypothesis requires further epidemiological and clinical confirmation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/2162402x.2024.2413719

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Negative effects of diazepam on immunochemotherapy in mice. Following the schedule of cancer cell inoculation and drug administration to C57BL/6J mice depicted in the scheme (a), the effect of various treatments regimens on the growth of MCA205 fibrosarcomas was assessed. Results are shown as mean tumor size ± standard error of the mean (b) and Kaplan-Meyer plots of the animal survival (c). P-values corresponding to the pairwise comparisons among treatment groups are displayed in a matrix (d). Tumor growth rates were compared with the TumGrowth tool (https://kroemerlab.Shinyapps.io/TumGrowth) by linear mixed effect modeling. Survival differences were tested using log-rank (mantel-cox) test. ACBP: acyl coA binding protein (ACBP/DBI); CT: chemotherapy; PD-1: programmed cell death protein 1.
Figure 1. Negative effects of diazepam on immunochemotherapy in mice. Following the schedule of cancer cell inoculation and drug administration to C57BL/6J mice depicted in the scheme (a), the effect of various treatments regimens on the growth of MCA205 fibrosarcomas was assessed. Results are shown as mean tumor size ± standard error of the mean (b) and Kaplan-Meyer plots of the animal survival (c). P-values corresponding to the pairwise comparisons among treatment groups are displayed in a matrix (d). Tumor growth rates were compared with the TumGrowth tool (https://kroemerlab.Shinyapps.io/TumGrowth) by linear mixed effect modeling. Survival differences were tested using log-rank (mantel-cox) test. ACBP: acyl coA binding protein (ACBP/DBI); CT: chemotherapy; PD-1: programmed cell death protein 1.CC BY · PubMed Central
Figure 2. Benzodiazepines and the endozepine ACBP/DBI share a poor prognosis effect in non-small cell lung cancer patients. Kaplan-Meier curves of non-small cell lung cancer (NSCLC) patients included in the ONCOBIOTICS and CRCHUM lung cancer biobank observational studies on comedications demonstrate that the use of benzodiazepines (BZD) during therapy has a negative effect on progression-free survival (PFS, a) and a trend for worsening overall survival (OS, b). These effects were not observed with other psychiatric comedications (PSY not BZD). Circulating levels of ACBP/DBI were quantified by ELISA in the plasma from patients with NSCLC participating to the CRCHUM study (c, N = 121 patients with available plasma for ACBP measurements). Survival datasets are displayed as Kaplan-Meier curves and were compared by log-rank Mantel-Cox test, plasma concentrations were compared overall across the three groups by Kruskal-Wallis test.
Figure 2. Benzodiazepines and the endozepine ACBP/DBI share a poor prognosis effect in non-small cell lung cancer patients. Kaplan-Meier curves of non-small cell lung cancer (NSCLC) patients included in the ONCOBIOTICS and CRCHUM lung cancer biobank observational studies on comedications demonstrate that the use of benzodiazepines (BZD) during therapy has a negative effect on progression-free survival (PFS, a) and a trend for worsening overall survival (OS, b). These effects were not observed with other psychiatric comedications (PSY not BZD). Circulating levels of ACBP/DBI were quantified by ELISA in the plasma from patients with NSCLC participating to the CRCHUM study (c, N = 121 patients with available plasma for ACBP measurements). Survival datasets are displayed as Kaplan-Meier curves and were compared by log-rank Mantel-Cox test, plasma concentrations were compared overall across the three groups by Kruskal-Wallis test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 18

Metadata

Authors
Montégut, L., Derosa, L., Messaoudene, M., Chen, H., Lambertucci, F., Routy, B., Zitvogel, L., Martins, I., & Kroemer, G.
Affiliations
  • Institut Gustave Roussy (FR)
  • Inserm (FR)
  • Centre Hospitalier de l’Université de Montréal (CA)
Corresponding author
  • Martins, Isabelle
  • Kroemer, Guido
Venue
OncoImmunology
Published
2024-10-07
Volume
13
Issue
1
Pages
2413719-2413719
ISSN
  • 2162-4011 (ISSN-L)
  • 2162-402X
OpenAlex
W4403190877
Cited by
18
References
51
Citations by year
2026: 8 · 2025: 10
FWCI
3.07
Type
journal article
Language
en
Open access
Locations
  • OncoImmunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Agence Nationale de la Recherche
  • Association pour la Recherche sur le Cancer
  • Cancéropôle Ile de France
  • Fondation pour la Recherche Médicale
  • HORIZON EUROPE European Research Council
  • Institut National Du Cancer
  • Institut Universitaire de France
  • Labex Immuno-Oncology
  • Ligue Contre le Cancer
  • Hevolution Network on Senescence and Aging
  • Elior
  • EJPRD
  • Mark foundation
  • Seerave Foundation
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Keywords
benzodiazepines, diazepam, cancer immunotherapy, chemoimmunotherapy, immunosuppression, GABAA receptor, positive allosteric modulators, non-small cell lung cancer, psychotropic drugs
MeSH terms
Animals, Benzodiazepines, Diazepam, Humans, Immunotherapy, Lung Neoplasms, Neoplasms, Treatment Outcome, Diazepam Binding Inhibitor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Benzodiazepines compromise the outcome of cancer immunotherapy. https://app.cochat.ai/papers/10.1080/2162402x.2024.2413719
The paper
Montégut, L., Derosa, L., Messaoudene, M., Chen, H., Lambertucci, F., Routy, B., Zitvogel, L., Martins, I., & Kroemer, G. (2024). Benzodiazepines compromise the outcome of cancer immunotherapy. OncoImmunology. https://doi.org/10.1080/2162402x.2024.2413719

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.